How India's drug regulatory regime can ensure greater credibility for our pharma industry
It must move from being a manufacturer of generic drugs to becoming one associated with quality generic/innovative drugs
Stay updated with breaking news from Action Indications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It must move from being a manufacturer of generic drugs to becoming one associated with quality generic/innovative drugs
Bloomberg. thank you very much. can ou talk bloomberg. thank you very much. can you talk about — bloomberg. thank you very much. can you talk about two _ bloomberg. thank you very much. can you talk about two things, _ bloomberg. thank you very much. can you talk about two things, censure - you talk about two things, censure president— you talk about two things, censure president of china has you seen any indications — president of china has you seen any indications of action or lack of action— indications of action or lack of action from china that is lead you to believe whether they ...